Journal of Pharmacy and Bioallied Sciences (May 2025)

Systemic Review to Explore the Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus: In Tertiary Care Center

  • Akansha Singh,
  • Ranjit S. Ambad,
  • Roshan K. Jha

DOI
https://doi.org/10.4103/jpbs.jpbs_1976_24
Journal volume & issue
Vol. 17, no. Suppl 1
pp. S127 – S129

Abstract

Read online

Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein cholesterol (HDL-C) are highly prevalent in type 2 diabetes mellitus (T2DM). The extent to which diabetes mellitus–related abnormalities in the triglyceride HDL-C profile associates with cardiovascular disease (CVD) risk is incompletely understood. We evaluated the associations of triglyceride and HDL-C status with CVD outcomes in individuals with T2DM. This meta-analysis aims to evaluate the effect of dyslipidaemia and metabolic function in coronary heart disease with type 2 diabetes mellitus by pooling data from multiple studies.

Keywords